Abstract

Aim To evaluate the performance of three contrast media (CM) injection protocols for cardiac computed tomography angiography (CCTA) based on body weight (BW), lean BW (LBW), and cardiac output (CO). Materials and methods. A total of 327 consecutive patients referred for CCTA were randomized into one of the three CM injection protocols, where CM injection was based on either BW (112 patients), LBW (108 patients), or CO (107 patients). LBW and CO were calculated via formulas. All scans were ECG-gated and performed on a third-generation dual-source CT with 70–120 kV (automated tube voltage selection) and 100 kVqual.ref/330 mAsqual.ref. CM injection protocols were also adapted to scan time and tube voltage. The primary outcome was the proportion of patients with optimal intravascular attenuation (325–500 HU). Secondary outcomes were mean and standard deviation of intravascular attenuation values (HU), contrast-to-noise ratio (CNR), and subjective image quality with a 4-point Likert scale (1 = poor/2 = sufficient/3 = good/4 = excellent). The t-test for independent samples was used for pairwise comparisons between groups, and a chi-square test (χ2) was used to compare categorical variables between groups. All p values were 2-sided, and a p < 0.05 was considered statistically significant. Results Mean overall HU and CNR were 423 ± 60HU/14 ± 3 (BW), 404 ± 62HU/14 ± 3 (LBW), and 413 ± 63HU/14 ± 3 (CO) with a significant difference between groups BW and LBW (p=0.024). The proportion of patients with optimal intravascular attenuation (325–500 HU) was 83.9%, 84.3%, and 86.9% for groups BW, LBW, and CO, respectively, and between-group differences were small and nonsignificant. Mean CNR was diagnostic (≥10) in all groups. The proportion of scans with good-excellent image quality was 94.6%, 86.1%, and 90.7% in the BW, LBW, and CO groups, respectively. The difference between proportions was significant between the BW and LBW groups. Conclusion Personalization of CM injection protocols based on BW, LBW, and CO, and scan time and tube voltage in CCTA resulted in low variation between patients in terms of intravascular attenuation and a high proportion of scans with an optimal intravascular attenuation. The results suggest that personalized CM injection protocols based on LBW or CO have no additional benefit when compared with CM injection protocols based on BW.

Highlights

  • Cardiac computed tomography angiography (CCTA) is a valuable tool in ruling out coronary artery disease because of its high negative predictive value (99%) [1,2,3,4]

  • An intravascular attenuation >500 HU could lead to an underestimation of coronary calcifications [13]. erefore, intravascular attenuation in CCTA should ideally lie within an intravascular attenuation “window” of 325–500HU

  • Is study addresses the question of whether there are differences in performance between personalized CM injection protocols based on BW, lean body weight (LBW), or CO. e hypothesis is that personalization on either one of these three parameters does not result in a significantly different image quality. erefore, the aim of this study is to evaluate the performance of three individualized protocols based on BW, LBW, and CO for CCTA

Read more

Summary

Introduction

Cardiac computed tomography angiography (CCTA) is a valuable tool in ruling out coronary artery disease because of its high negative predictive value (99%) [1,2,3,4]. Diagnostic accuracy for coronary artery assessment is achieved with a diagnostic intravascular attenuation (measured in Houns eld units (HU)) and contrast-to-noise ratio (CNR). Contrast Media & Molecular Imaging media injection protocol (CM) (e.g., concentration, iodine delivery rate (IDR)), and patient-related factors (e.g., cardiac output (CO) and body weight (BW)) [7,8,9]. IDR, which refers to the grams of iodine injected per second, is the most important factor for achieving diagnostic intravascular attenuation in CCTA [10,11,12]. Intravascular attenuation should be high enough to assess the coronary arteries (≥325HU) [7]. An intravascular attenuation >500 HU could lead to an underestimation of coronary calcifications [13]. erefore, intravascular attenuation in CCTA should ideally lie within an intravascular attenuation “window” of 325–500HU

Objectives
Methods
Results

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.